Bafna Pharmaceuticals Management
Management criteria checks 4/4
Bafna Pharmaceuticals' CEO is Bansilal Mahaveer Bafna, appointed in Dec 2005, has a tenure of 18.42 years. directly owns 0.027% of the company’s shares, worth ₹694.91K. The average tenure of the management team and the board of directors is 7 years and 3.5 years respectively.
Key information
Bansilal Mahaveer Bafna
Chief executive officer
₹3.6m
Total compensation
| CEO salary percentage | n/a |
| CEO tenure | 18.4yrs |
| CEO ownership | 0.03% |
| Management average tenure | 7yrs |
| Board average tenure | 3.5yrs |
Recent management updates
Recent updates
We Think Bafna Pharmaceuticals (NSE:BAFNAPH) Can Stay On Top Of Its Debt
Aug 15
Optimistic Investors Push Bafna Pharmaceuticals Limited (NSE:BAFNAPH) Shares Up 27% But Growth Is Lacking
Feb 13The Strong Earnings Posted By Bafna Pharmaceuticals (NSE:BAFNAPH) Are A Good Indication Of The Strength Of The Business
Nov 19Do Its Financials Have Any Role To Play In Driving Bafna Pharmaceuticals Limited's (NSE:BAFNAPH) Stock Up Recently?
Dec 10CEO Compensation Analysis
| Date | Total Compensation | Salary | Company Earnings |
|---|---|---|---|
| Dec 31 2023 | n/a | n/a | ₹113m |
| Sep 30 2023 | n/a | n/a | ₹172m |
| Jun 30 2023 | n/a | n/a | ₹163m |
| Mar 31 2023 | ₹4m | n/a | ₹113m |
| Dec 31 2022 | n/a | n/a | ₹50m |
| Sep 30 2022 | n/a | n/a | ₹37m |
| Jun 30 2022 | n/a | n/a | ₹44m |
| Mar 31 2022 | ₹4m | n/a | ₹52m |
| Dec 31 2021 | n/a | n/a | ₹88m |
| Sep 30 2021 | n/a | n/a | ₹80m |
| Jun 30 2021 | n/a | n/a | ₹61m |
| Mar 31 2021 | ₹3m | n/a | ₹58m |
| Dec 31 2020 | n/a | n/a | ₹256m |
| Sep 30 2020 | n/a | n/a | ₹28m |
| Jun 30 2020 | n/a | n/a | ₹18m |
| Mar 31 2020 | ₹2m | ₹2m | -₹19m |
| Dec 31 2019 | n/a | n/a | -₹394m |
| Sep 30 2019 | n/a | n/a | -₹178m |
| Jun 30 2019 | n/a | n/a | -₹196m |
| Mar 31 2019 | ₹2m | ₹2m | -₹199m |
| Mar 31 2018 | ₹2m | ₹2m | -₹167m |
Compensation vs Market: Bansilal Mahaveer's total compensation ($USD43.10K) is about average for companies of similar size in the Indian market ($USD39.52K).
Compensation vs Earnings: Bansilal Mahaveer's compensation has been consistent with company performance over the past year.
CEO
Bansilal Mahaveer Bafna (62 yo)
18.4yrs
Tenure
₹3,600,000
Compensation
Mr. Bansilal Mahaveer Chand Bafna has been Chief Executive Officer of Bafna Pharmaceuticals Limited since September 10, 2020 and served as Chairman and Managing Director of Bafna Pharmaceuticals Limited si...
Leadership Team
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Chief Executive Officer | 18.4yrs | ₹3.60m | 0.027% ₹ 694.9k | |
| Chief Financial Officer | 7yrs | ₹1.19m | no data | |
| Executive Chairman | 3.7yrs | no data | no data | |
| Additional Whole-Time Director of Operation | less than a year | no data | no data |
7.0yrs
Average Tenure
55yo
Average Age
Experienced Management: BAFNAPH's management team is seasoned and experienced (7 years average tenure).
Board Members
| Name | Position | Tenure | Compensation | Ownership |
|---|---|---|---|---|
| Executive Chairman | 3.7yrs | no data | no data | |
| Additional Whole-Time Director of Operation | less than a year | no data | no data | |
| Non-Executive & Independent Director | 3.9yrs | ₹110.00k | no data | |
| Additional Non-Executive Non-Independent Director | less than a year | no data | no data | |
| Non-Executive & Independent Director | 3.5yrs | ₹90.00k | no data | |
| Non-Executive & Non-Independent Director | 3.7yrs | no data | no data | |
| Non-Executive Independent Director | less than a year | no data | no data |
3.5yrs
Average Tenure
41yo
Average Age
Experienced Board: BAFNAPH's board of directors are considered experienced (3.5 years average tenure).